Childhood Cancer

You are here

Home » Grants » All grants tagged with "Acute Lymphoblastic Leukemia (ALL)"

All grants tagged with "Acute Lymphoblastic Leukemia (ALL)"

Single Cell Analysis of Leukemia Initiation
Michael Cleary, MD
Stanford University
Innovation Grants, Awarded 2015
Functional Dissection of Oncogenic Enhancers in T-ALL
Daniel Herranz, PhD
Columbia University
Young Investigator Grants, Awarded 2015
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor
Shuning He, PhD
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2015
The Effect of Locus of Care Upon Adolescent and Young Adults Cancer Outcomes: An IMPACT Cohort Study
Sumit Gupta, MD, PhD
Hospital for Sick Children
Young Investigator Grants, Awarded 2015
The Role of PARP3 in the Formation of Chromosomal Translocations
Tovah Day, PhD
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2015
Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia
John Nikitas
Washington University
POST Program Grants, Awarded 2015
FLT3 Receptor-Redirected Chimeric Antigen Receptor T Cells for AML and ALL
William Fix
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2015
Characterization of Genetic Risk Factors for Adverse Effects of ALL Therapy in Asian Children
Tomoya Isobe
St. Jude Children’s Research Hospital
POST Program Grants, Awarded 2015
Neurocognitive Assessments within COG: An Intensive, Integrated Model for Successfully Evaluating Children with High-Risk ALL
Kristina Hardy, PhD
Children’s Research Institute
Psychosocial Grants, Awarded 2014
HA-1 TCR T-cell Immunotherapy for Acute Leukemia
Marie Bleakley, M.D., Ph.D.
Fred Hutchinson Cancer Research Center
Bio-Therapeutic Impact Award, Awarded 2014

Pages

All childhood cancer types

Featured Hero

Huxley Rogers

Hux is 7 years old and a party animal who loves dancing. Since he was diagnosed with Phelan-MCDermid syndrome at birth, he gets yearly brain MRIs - and one revealed a tumor when Hux turned 3. After a year of treatment, Hux has remained cancer-free!
Read more »